{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:52:12Z","timestamp":1790815932058,"version":"4.1.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T00:00:00Z","timestamp":1207094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T00:00:00Z","timestamp":1207094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1208\/s12249-008-9073-5","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T21:12:49Z","timestamp":1207084369000},"page":"505-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["A Review of Current Intravaginal Drug Delivery Approaches Employed for the Prophylaxis of HIV\/AIDS and Prevention of Sexually Transmitted Infections"],"prefix":"10.1208","volume":"9","author":[{"given":"Valence M. K.","family":"Ndesendo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viness","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya E.","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhart","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Bayever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leith C. R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,2]]},"reference":[{"key":"9073_CR1","unstructured":"HIV and its transmission. Division of HIV\/AIDS Prevention, 2003. Available at: Center for Disease Control and Prevention. Accessed May 23, 2006."},{"key":"9073_CR2","unstructured":"How HIV is spread. San Francisco AIDS Foundation. Available at: www.iapac.org. Accessed May 23, 2006."},{"issue":"5","key":"9073_CR3","first-page":"512","volume":"40","author":"O. Pusch","year":"2005","unstructured":"O. Pusch, D. Boden, S. Hannify, F. Lee, et al. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J. AIDS. 40(5):512\u2013520 (2005).","journal-title":"J. AIDS"},{"key":"9073_CR4","unstructured":"Overview of the global AIDS epidemic. Report on the global AIDS epidemic, UNAIDS\/WHO. Available at: http:\/\/www.cmaj.ca\/cgi\/content\/full\/176\/12\/172. Accessed June 8, 2006."},{"key":"9073_CR5","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1136\/bmj.326.7403.1384","volume":"326","author":"E. Pisani","year":"2003","unstructured":"E. Pisani, G. P. Garnett, N. C. Grassly, et al. Back to basics in HIV prevention: focus on exposure. BMJ. 326:1384\u20131387 (2003).","journal-title":"BMJ"},{"key":"9073_CR6","unstructured":"K. R. Malcolm, and D. A. Woolfson. Delivery hope on HIV-Vaginal rings for controlled release of microbicides. J Controlled Release. 52\u201355 (2006)."},{"issue":"3","key":"9073_CR7","first-page":"45","volume":"5","author":"J. Berger","year":"2004","unstructured":"J. Berger. Re-sexualizing the Epidemic: Desire, risk and HIV prevention. Dev. Update. 5(3):45\u201367 (2004).","journal-title":"Dev. Update"},{"issue":"4","key":"9073_CR8","first-page":"511","volume":"41","author":"T. J. Brown","year":"1999","unstructured":"T. J. Brown, A. Yen-Moore, and S. K. Trying. An overview of sexually transmitted diseases. Part 1. J. Am. Acad. Dermatol. 41(4):511\u2013532 (1999).","journal-title":"J. Am. Acad. Dermatol."},{"key":"9073_CR9","unstructured":"Sexually transmitted infections (STIs). Drug Digest, 2004. Available at: http:\/\/www.drugdigest.org\/DD\/PrintablePages\/HealthConditions\/1,20041,550367,00.html. Accessed April 20, 2007."},{"key":"9073_CR10","unstructured":"Sexually transmitted Infections (STIs) as a public health issue. Facts sheets, WHO, 2004. Available at: http:\/\/www.who.int\/reproductive-health\/stis\/docs\/sti_factsheet_2004.pdf. Accessed April 22, 2007."},{"key":"9073_CR11","volume-title":"Umthenthe Uhlaba Usamila \u2013 The South African Youth Risk Behaviour Survey 2002","author":"S. P. Reddy","year":"2003","unstructured":"S. P. Reddy, D. Swart, C. C. Jinabhai, S. L. Amosun, S. James, K. D. Monyeki, G. Stevens, N. Morejele, N. S. Kambaram, R. G. Omardien, and H. W. Van den Borne. Umthenthe Uhlaba Usamila \u2013 The South African Youth Risk Behaviour Survey 2002, South African Medical Research Council, Cape Town, 2003."},{"key":"9073_CR12","unstructured":"A. E. Pettifor, H. V. Rees, A. Steffenson, L. Hlongwa-Madikizela, C. MacPhail, K. Vermaak, and I. Kleinschmidt. HIV and sexual behavior among young South Africans: a national survey of 15\u201324\u00a0year olds. Reproductive Health Research Unit, University of the Witwatersrand. Available at http:\/\/www.rhruco.za\/images\/Docs\/national%20survey%20RHRU.pdf. Accessed November, 2007."},{"key":"9073_CR13","volume-title":"Contraceptive Technology","author":"R. Hatcher","year":"2004","unstructured":"R. Hatcher, et al. Contraceptive Technology, 18th ed., Ardent Media, Inc., New York, 2004.","edition":"18"},{"issue":"5","key":"9073_CR14","doi-asserted-by":"publisher","first-page":"0392","DOI":"10.1371\/journal.pmed.0020142","volume":"2","author":"J. Weber","year":"2005","unstructured":"J. Weber, K. Desai, and J. Darbyshire. The development of vaginal microbicides for the prevention of HIV transmission. PLoS Medicine. 2(5):0392\u20130395 (2005).","journal-title":"PLoS Medicine"},{"issue":"10","key":"9073_CR15","first-page":"359","volume":"3","author":"K. Verman","year":"2000","unstructured":"K. Verman, and S. Garg. The scope and potential of vaginal drug delivery. PSTT. 3(10):359\u2013364 (2000).","journal-title":"PSTT"},{"key":"9073_CR16","first-page":"2656","volume":"6 and 30","author":"D. F. Katz","year":"1997","unstructured":"D. F. Katz, E. N. Dunmire, M. H. Henderson, D. H. Owen, and A. M. Plenys. Applications of biomedical engineering in reproductive biomedicine: sensing and drug delivery to the lower female reproductive tract. Eng. Med. Biol. Soc. 6 and 30:2656\u20132658 (1997).","journal-title":"Eng. Med. Biol. Soc."},{"key":"9073_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.eurpolymj.2004.10.017","volume":"41","author":"C. Tang","year":"2005","unstructured":"C. Tang, C. Yin, Y. Pen, et al. New superporous hydrogels composites based on aqueous carbopol\u00ae solution (SPHCcs): Synthesis, characterization and in vitro bioadhesive force studies. Eur. Polym. J. 41:557\u2013562 (2005).","journal-title":"Eur. Polym. J."},{"issue":"11","key":"9073_CR18","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.addr.2005.07.004","volume":"57","author":"C. Valenta","year":"2005","unstructured":"C. Valenta. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev. 57(11):1692\u20131712 (2005).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"9073_CR19","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1208\/pt0704104","volume":"7","author":"M. C. Bonferoni","year":"2006","unstructured":"M. C. Bonferoni, P. Giunchedi, S. Scalia, et al. Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSciTech. 7(4):E1\u2013E8 (2006).","journal-title":"AAPS PharmSciTech."},{"issue":"1","key":"9073_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/187221107779814113","volume":"1","author":"K. Al-Tahami","year":"2007","unstructured":"K. Al-Tahami, and J. Singh. Smart polymer based delivery systems for peptides and proteins. Recent Patents on Drug Delivery and Formulation. 1(1):65\u201371 (2007).","journal-title":"Recent Patents on Drug Delivery and Formulation"},{"key":"9073_CR21","unstructured":"C. W. Lew. Controlled release pH sensitive capsule and adhesive system and method. US Patent 5364634 (1994)."},{"key":"9073_CR22","unstructured":"C. Bogentoft, and A. Carlsson. Gel forming liquid carrier composition. US Patent 5492937 (1996)."},{"key":"9073_CR23","unstructured":"J. R. Robinson, and W. J. Bologna. Use of polycarboxylic acid polymers to treat vaginal infections. US Patent 6017521 (2002)."},{"key":"9073_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G","volume":"89","author":"W. J. Lee","year":"2000","unstructured":"W. J. Lee, J. H. Park, and J. R. Robinson. Bioadhesive-based dosage forms: The next generation. J. Pharm. Sci. 89:850\u2013866 (2000).","journal-title":"J. Pharm. Sci."},{"key":"9073_CR25","unstructured":"HIV Vaginal Gel: An overview of PRO 2000. Mom A. Available at: http:\/\/www.associatedcontent.com\/article\/92443\/HIV_vaginal_gel_an_overview_of_pro.html. Accessed March 24, 2006."},{"key":"9073_CR26","unstructured":"South Africa: Microbicide trial failure. Thom A. Available at: http:\/\/allafrica.com\/stories\/200702010864.htm. Accessed February 2, 2007."},{"key":"9073_CR27","unstructured":"P. Penttinen. Microbicides as an option for HIV prevention, A Report for the International Task Force on Global Public Goods (2005)."},{"issue":"16","key":"9073_CR28","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2174\/138161206777442119","volume":"12","author":"A. S. Bourinbaiar","year":"2006","unstructured":"A. S. Bourinbaiar, R. S. Root-Bernstein, R. Abulafia-Lapid, P. G. Rytik, V. Kanev, A. N. Jirathitikal, and V. G. Orlovsky. Therapeutic AIDS vaccines. Curr. Pharm. Des. 12(16):2017\u20132030 (2006).","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"9073_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.trstmh.2005.01.007","volume":"99","author":"S. N. Joshi","year":"2005","unstructured":"S. N. Joshi, U. Katti, S. Godbole, K. Bharucha, S. Kulkarini, A. Risbud, and S. Mahendale. Phase I safety study of praneem polyherbral vaginal tablet use among HIV-uninfected women in Pune, India. Trans. R. Soc. Trop. Med. Hyg. 99(10):769\u2013774 (2005).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"9073_CR30","first-page":"1","volume":"20","author":"K. Best","year":"2000","unstructured":"K. Best. Microbicide products enter human trials. FHI\u2019s Prevention Trials Network. 20(2):1\u201312 (2000).","journal-title":"FHI\u2019s Prevention Trials Network"},{"key":"9073_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jac\/dkh011","volume":"52","author":"J. P. Moore","year":"2003","unstructured":"J. P. Moore, and R. J. Shattock. Preventing HIV-1 sexual transmission\u2014not sexy enough science, or no benefit to the bottom line? J. Antimicrob. Chemother. 52:890\u2013892 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"9073_CR32","first-page":"81","volume-title":"Biotech and Genetic Eng Rev","author":"K. R. Malcolm","year":"2004","unstructured":"K. R. Malcolm, D. A. Woolfson, C. Toner, et al. Vaginal microbicides for the prevention of HIV transmission. In S. E. Harding (ed.), Biotech and Genetic Eng Rev, Intercept Ltd., Dorset, 2004, pp. 81\u2013121."},{"key":"9073_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1086\/499163","volume":"193","author":"D. Dhawan","year":"2006","unstructured":"D. Dhawan, and K. H. Mayer. Microbicides to prevent HIV transmission: Overcoming obstacles to chemical barrier protection. J. Infect. Dis. 193:36\u201344 (2006).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"9073_CR34","first-page":"1","volume":"8","author":"V. Holmes","year":"2007","unstructured":"V. Holmes, B. Ramratnam, S. U. Hartmann, et al. Developing a microbicide containing CCR5 siRNA for preventing the transmission of human immunodeficiency virus type 1 (HIV-1). Alliance for Microbicides Development. 8(3):1\u201321 (2007).","journal-title":"Alliance for Microbicides Development"},{"issue":"1","key":"9073_CR35","first-page":"77","volume":"5","author":"D. S. Nikolic","year":"2007","unstructured":"D. S. Nikolic, E. Garcia, and V. Piguet. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections. Future Drugs. 5(1):77\u201388 (2007).","journal-title":"Future Drugs"},{"key":"9073_CR36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i5.30","volume":"17","author":"A. D. Woolfson","year":"2000","unstructured":"A. D. Woolfson, R. K. Malcolm, and R. Gallagher. Drug delivery by the intravaginal route. Crit. Rev. Ther. Drug Carr. Syst. 17:509\u2013555 (2000).","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"issue":"4","key":"9073_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2165\/00137696-200301040-00003","volume":"1","author":"A. Benkop-Schnurch","year":"2003","unstructured":"A. Benkop-Schnurch, and M. Hornof. Intravaginal drug delivery systems: Design, Challenges and Solutions. Am. J Drug Delivery. 1(4):241\u2013254 (2003).","journal-title":"Am. J Drug Delivery"},{"key":"9073_CR38","doi-asserted-by":"crossref","unstructured":"A. Stone. MICROBICIDES: A new approach to preventing HIV and other sexually transmitted infections. Nature Reviews (2002).","DOI":"10.1038\/nrd959"},{"key":"9073_CR39","unstructured":"A molecular condom against AIDS. P. Kiser. Available at: http:\/\/unews.utah.edu\/p\/?r=111706\u20132, 1\u20133. Accessed March 26, 2007."},{"key":"9073_CR40","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/00002030-200307250-00003","volume":"17","author":"S. Di Fabio","year":"2003","unstructured":"S. Di Fabio, J. Van Roey, G. Giannini, et al. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS. 17:1597\u20131604 (2003).","journal-title":"AIDS"},{"key":"9073_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/AAC.48.1.337-339.2004","volume":"48","author":"Y. V. Herrewege","year":"2004","unstructured":"Y. V. Herrewege, J. Michiels, J. Van Roey, et al. In vitro evaluation of non-nucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrob Agents Chemother. 48:337\u2013339 (2004).","journal-title":"Antimicrob Agents Chemother."},{"key":"9073_CR42","unstructured":"Microbicide Research and Development Database, 2005. Alliance for Microbicide Development. Available at: http:\/\/secure.microbicide.org\/NetReports\/ClinicalTrialsOngoingByProduct.aspx. Accessed July 21, 2007."},{"key":"9073_CR43","unstructured":"D. Mitchel. Focus renewed on HIV microbicides. International Health Conference, Canada, 2006."},{"issue":"1\u20132","key":"9073_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijpharm.2004.06.016","volume":"282","author":"Y. Wang","year":"2004","unstructured":"Y. Wang, and H. C. Lee. Effects of intrinsic variables on release of sodium dodecyl sulfate from a female controlled drug delivery system. Int. J. Pharm. 282(1\u20132):173\u2013181 (2004).","journal-title":"Int. J. Pharm."},{"issue":"2","key":"9073_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/pt070238","volume":"7","author":"E. Bilensoy","year":"2006","unstructured":"E. Bilensoy, A. M. Rouf, I. Vural, M. Sen, and A. A. Hincal. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole cyclodextrin complex. AAPS PharmSciTech. 7(2):1\u201313 (2006).","journal-title":"AAPS PharmSciTech."},{"issue":"4","key":"9073_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/ps040419","volume":"4","author":"A. El-Kamel","year":"2002","unstructured":"A. El-Kamel, M. Soker, V. Naggar, and S. Al Gamal. Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PharmSciTech. 4(4):1\u20138 (2002).","journal-title":"AAPS PharmSciTech."},{"issue":"3","key":"9073_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02830615","volume":"3","author":"E. Gavin","year":"2002","unstructured":"E. Gavin, V. Sanna, C. Juliano, C. M. Benfero, and P. Giunchedi. Mucoadhesive vaginal tablets as veterinary system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSciTech. 3(3):1\u20137 (2002).","journal-title":"AAPS PharmSciTech."},{"issue":"1","key":"9073_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0378-5173(01)00900-0","volume":"232","author":"J. A. H. van Laarhoven","year":"2002","unstructured":"J. A. H. van Laarhoven, M. A. B. Kruft, and H. Vromans. In vitro release properties of etonogestrol and ethinyl estradiol from a contraceptive vaginal ring. Int. J. Pharm. 232(1):163\u2013173 (2002).","journal-title":"Int. J. Pharm."},{"key":"9073_CR49","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/374834","volume":"26","author":"P. F. Harrison","year":"2003","unstructured":"P. F. Harrison, Z. Rosenberg, and J. Bowcut. Topical microbicides for disease prevention: Status and challenges. Clin. Infect. Dis. 26:1290\u20131294 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"9073_CR50","unstructured":"L. van Damme. Alliance for microbicide development. Health and Sexuality Microbicides. Special report, 1\u20138 (2002)."},{"issue":"5","key":"9073_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0010-7824(02)00433-X","volume":"66","author":"L. van Damme","year":"2002","unstructured":"L. van Damme, E. Adriens, and G. Ramjee. The evaluation of the local tolerance of vaginal formulations with or without nonxynolol-9 using the slug mucosal irritation test. Contraception. 66(5):369\u2013375 (2002).","journal-title":"Contraception"},{"issue":"3","key":"9073_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1381612043386374","volume":"10","author":"O. J. D\u2019Cruz","year":"2004","unstructured":"O. J. D\u2019Cruz, and F. M. UcKun. Clinical development of microbicides for the prevention of HIV infection. Curr. Pharm. Design. 10(3):315\u2013335 (2004).","journal-title":"Curr. Pharm. Design"},{"key":"9073_CR53","first-page":"202","volume":"70","author":"V. E. Johnson","year":"1962","unstructured":"V. E. Johnson, and W. H. Masters. Intravaginal contraceptive study: Phase I. Anatomy. West. J. Surg. Obstet. Gynecol. 70:202\u2013207 (1962).","journal-title":"West. J. Surg. Obstet. Gynecol."},{"key":"9073_CR54","first-page":"2656","volume":"6 and 30","author":"D. F. Katz","year":"1997","unstructured":"D. F. Katz, E. N. Dunmire, M. H. Henderson, D. H. Owen, and A. M. Plenys. Applications of biomedical engineering in reproductive biomedicine: sensing and drug delivery to the lower female reproductive tract. Engineering in Medicine and Biology society. 6 and 30:2656\u20132658 (1997).","journal-title":"Engineering in Medicine and Biology society"},{"key":"9073_CR55","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00007435-199803000-00012","volume":"25","author":"L. DuBouchet","year":"1998","unstructured":"L. DuBouchet, J. A. McGregor, M. Ismail, and W. M. McCormack. A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of trichomonas vaginalis vaginitis. Sex. Transm. Dis. 25:176\u2013179 (1998).","journal-title":"Sex. Transm. Dis."},{"key":"9073_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/10647440300025519","volume":"11","author":"R. F. Lamont","year":"2003","unstructured":"R. F. Lamont, B. M. Jones, D. Mandal, P. E. Hay, and M. Sheehan. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect. Dis. Obstet. Gynecol. 11:181\u2013189 (2003).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"9073_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0168-3659(99)00017-6","volume":"60","author":"D. H. Owen","year":"1999","unstructured":"D. H. Owen, E. N. Dunmire, A. M. Planys, and D. F. Katz. Factors influencing nonoxynol-9 permeation and bioactivity in cervical mucus. J. Control Release. 60:23\u201334 (1999).","journal-title":"J. Control Release"},{"key":"9073_CR58","unstructured":"S. Yiv, M. Li, O. D\u2019Cruz, and F. M. Uckun. Gel-microencapsulation formulations. USP Patent 064114, June 20, 2006."},{"key":"9073_CR59","first-page":"31","volume":"40","author":"J. Paavonen","year":"1983","unstructured":"J. Paavonen. Physiology and ecology of the vagina. Scand. J. Infect. Dis. 40:31\u201335 (1983).","journal-title":"Scand. J. Infect. Dis."},{"key":"9073_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000293685","volume":"26","author":"S. S. Cajander","year":"1988","unstructured":"S. S. Cajander, and E. Rylander. Morphometric characteristics of the vaginal epithelium during the menstrual cycle. Gynecol Obstet. Invest. 26:136\u2013144 (1988).","journal-title":"Gynecol Obstet. Invest."},{"key":"9073_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000293657","volume":"27","author":"H. Pschera","year":"1989","unstructured":"H. Pschera, A. Hjerpe, and K. Carlstrom. Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17-b and progesterone in postmenopausal women. Gynecol. Obstet. Invest. 27:204\u2013207 (1989).","journal-title":"Gynecol. Obstet. Invest."},{"key":"9073_CR62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0169-409X(93)90017-X","volume":"11","author":"D. F. Katz","year":"1993","unstructured":"D. F. Katz, and E. N. Dunmire. Cervical mucus. Problems and opportunities for drug delivery via the vagina and cervix. Adv. Drug Deliv. Rev. 11:385\u2013401 (1993).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9073_CR63","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4049\/jimmunol.162.1.254","volume":"1","author":"L. S. Klavinskis","year":"1999","unstructured":"L. S. Klavinskis, M. Daheshia, K. Karem, E. Manickan, and B. T. Rouse. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal and rectal tracts. J. Immunol. 1:254\u2013262 (1999).","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"9073_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.06.026","volume":"325","author":"A. D. Woolfson","year":"2006","unstructured":"A. D. Woolfson, R. K. Malcom, R. J. Morrow, C. F. Tonner, and S. D. Mc Cullag. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicides. Int J Pharm. 325(1\u20132):82\u201389 (2006).","journal-title":"Int J Pharm."},{"key":"9073_CR65","first-page":"271","volume-title":"Physiological Pharmaceutics: Barriers to Drug Absorption","author":"N. Washington","year":"2001","unstructured":"N. Washington, C. Washington, and C. G. Wilson. Vaginal and intrauterine drug delivery. In N. Washington, C. Washington, and C. G. Wilson (eds.), Physiological Pharmaceutics: Barriers to Drug Absorption, Taylor and Francis, London, 2001, pp. 271\u2013281."},{"key":"9073_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0010-7824(98)00145-0","volume":"59","author":"F. J. M. E. Roumen","year":"1999","unstructured":"F. J. M. E. Roumen, and T. O. M. Dieben. Clinical acceptability of an ethylene-vinyl-acetate non-medicated vaginal ring. Contraception. 59:59\u201362 (1999).","journal-title":"Contraception"},{"key":"9073_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0010-7824(02)00514-0","volume":"67","author":"C. Nov\u00e1k","year":"2003","unstructured":"C. Nov\u00e1k, L. de la Loge, and E. A. van der Meulen. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 67:187\u2013194 (2003).","journal-title":"Contraception"},{"key":"9073_CR68","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1055\/s-2001-18646","volume":"19","author":"B. Harwood","year":"2001","unstructured":"B. Harwood, and D. R. Mishell. Contraceptive vaginal ring. Semin. Reprod. Med. 19:381\u2013390 (2001).","journal-title":"Semin. Reprod. Med."},{"key":"9073_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00003081-200103000-00014","volume":"44","author":"S. A. Ballagh","year":"2001","unstructured":"S. A. Ballagh. Vaginal ring hormone delivery systems in contraception and menopause. Clin. Obstet. Gynecol. 44:106\u2013113 (2001).","journal-title":"Clin. Obstet. Gynecol."},{"key":"9073_CR70","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1517\/14656566.4.2.201","volume":"4","author":"G. Dezarnaulds","year":"2002","unstructured":"G. Dezarnaulds, and I. S. Fraser. Vaginal ring delivery of hormone replacement therapy\u2014a review. Expt. Opin. Pharmacother. 4:201\u2013212 (2002).","journal-title":"Expt. Opin. Pharmacother."},{"key":"9073_CR71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1201\/b14099-22","volume-title":"Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches and Development","author":"J. L. Richardson","year":"1999","unstructured":"J. L. Richardson, and T. I. Armstrong. Vaginal delivery of calcitonin by hyaluronic acid formulations. In E. Mathiowitz, D. E. Chickering, and C. M. Lehr (eds.), Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches and Development, Marcel Dekker, New York, 1999, pp. 563\u2013599."},{"key":"9073_CR72","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/jps.2600651105","volume":"65","author":"S. Hwang","year":"1977","unstructured":"S. Hwang, E. O. Wada, T. Yotsuanagi, I. Suhardja, N. F. H. Ho, G. L. Flynn, and W. I. Higuchi. Systems approach to vaginal delivery of drugs: II. In situ vaginal absorption of unbranched aliphatic alcohols. J. Pharm. Sci. 65:1574\u20131578 (1977).","journal-title":"J. Pharm. Sci."},{"key":"9073_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0169-409X(93)90031-X","volume":"11","author":"L. Brannon-Peppas","year":"1992","unstructured":"L. Brannon-Peppas. Novel vaginal drug release applications. Adv. Drug Deliv. Rev. 11:169\u2013177 (1992).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9073_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/096032719000900202","volume":"9","author":"J. M. Sanders","year":"1990","unstructured":"J. M. Sanders, and H. B. Matthews. Vaginal absorption of polyvinyl alcohol in Fischer 344 rats. Human Exp. Toxicol. 9:71\u201377 (1990).","journal-title":"Human Exp. Toxicol."},{"key":"9073_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00003088-200140020-00001","volume":"40","author":"J. Woodley","year":"2001","unstructured":"J. Woodley. Bioadhesion: new possibilities for drug adhesion? Clin. Pharmacokinet. 40:77\u201384 (2001).","journal-title":"Clin. Pharmacokinet."},{"key":"9073_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0169-409X(93)90030-8","volume":"11","author":"K. Knuth","year":"1993","unstructured":"K. Knuth, M. Amiji, and J. R. Robinson. Hydrogel delivery systems for vaginal and oral applications: formulation and biological consideration. Adv. Drug Deliv. Rev. 11:137\u2013164 (1993).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9073_CR77","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1081\/DDC-100105179","volume":"27","author":"G. C. Ceschel","year":"2001","unstructured":"G. C. Ceschel, P. Maffei, S. L. Borgia, C. Ronchi, and S. Rossi. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev. Ind. Pharm. 27:541\u2013547 (2001).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"9073_CR78","unstructured":"S. Garg, K. Verman, R. A. Anderson, and L. J. Zaneveld. Rapidly disintegrating novel bioadhesive vaginal tablets of polystyrene sulfonate (PSS), a potential microbicide formulation [abstract]. International Conference of AIDS [serial online]. 2004; Abstract TuPeB4656."},{"issue":"3","key":"9073_CR79","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1095\/biolreprod.102.014555","volume":"69","author":"M. Perotti","year":"2003","unstructured":"M. Perotti, A. Pirovano, and D. M. Phillips. Carageenan formulation prevents macrophage trafficking from vagina: Implications for microbicide development. Biol. Reprod. 69(3):933\u2013939 (2003).","journal-title":"Biol. Reprod."},{"key":"9073_CR80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1021\/js9501876","volume":"85","author":"C. H. Lee","year":"1996","unstructured":"C. H. Lee, R. Bagdon, and Y. W. Chien. Comparative in vitro spermicidal activity and synergistic effect of chelating agents with nonoxynol-9 on human sperm functionality. J. Pharm. Sci. 85:91\u201395 (1996).","journal-title":"J. Pharm. Sci."},{"key":"9073_CR81","unstructured":"W. R. Blakemore, A. D. Ballard, C. J. Sewall, J. J. Modliszewski, and W. A. Bubnis. Inventors. Carageenan based antimicrobial compositions. US Patent 0171053 (2005)."},{"issue":"4","key":"9073_CR82","first-page":"245","volume":"16","author":"A. J. Smit","year":"2004","unstructured":"A. J. Smit. Medicinal and pharmaceutical uses of seaweed natural products: A review. J. App. Psych. 16(4):245\u2013262 (2004).","journal-title":"J. App. Psych."},{"issue":"1","key":"9073_CR83","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1095\/biolreprod54.1.173","volume":"54","author":"R. Pearce-Pratt","year":"1996","unstructured":"R. Pearce-Pratt, and D. M. Phillips. Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1. Biol. Reprod. 54(1):173\u2013182 (1996).","journal-title":"Biol. Reprod."},{"key":"9073_CR84","unstructured":"A. Forbes, and P. Harrison. Microbicides. Aids Community Research Initiative. America (2000)."},{"issue":"7","key":"9073_CR85","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1089\/jwh.2004.13.834","volume":"31","author":"M. Justin-Temu","year":"2004","unstructured":"M. Justin-Temu, F. Damian, R. Kinget, and G. Van Den Mooter. Intravaginal gels as drug delivery systems. J. Women\u2019s Health. 31(7):834\u2013843 (2004).","journal-title":"J. Women\u2019s Health"},{"key":"9073_CR86","unstructured":"N. Coetzee, A. Hoosen, K. Blanchard, A. de Kock, H. Sebda, B. Friedland, C. Ellerton, N. Nkompela, L Altin, G Ndlovu and K Tweedy. Safety of lambda carageenan microbicides (Carraguard\u2122) in South Africa. University of Cape Town, Medical University of Southern Africa, Population Council and Family Health International. 2006. Available at: http:\/\/www.itg.be\/micro2002\/downloads\/presentations\/2Monday_May_13_2002\/Track_B_sessions\/Nicol_Coetzee.pdf. Accessed October 17, 2007."},{"issue":"1","key":"9073_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.olq.0000223287.46097.4b","volume":"34","author":"A. Fern\u00e1ndez-Romero Jos\u00e9","year":"2007","unstructured":"A. Fern\u00e1ndez-Romero Jos\u00e9, T. Mitchell, G. Stuart, et al. Carrageenan\/MIV-150 (PC-815), a combination microbicide. Sex. Transm. Dis. 34(1):9\u201314 (2007).","journal-title":"Sex. Transm. Dis."},{"issue":"2","key":"9073_CR88","first-page":"0671","volume":"2","author":"B. C. Buck","year":"2006","unstructured":"B. C. Buck, C. D. Thompson, J. N. Roberts, et al. Carageenan is a potent inhibitor of papillomavirus infection. PloS Pathogens. 2(2):0671\u20130680 (2006).","journal-title":"PloS Pathogens"},{"key":"9073_CR89","unstructured":"B. M. Finley, C. J. Plescia, P. F. Harrison, and F. N. Vignes. An analytical overview of the microbicide preclinical and clinical pipeline. AIDS Conference. Toronto Canada; August, 2006."},{"issue":"4","key":"9073_CR90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/cdli.4.4.465-468.1997","volume":"4","author":"V. R. Zacharopoulos","year":"1997","unstructured":"V. R. Zacharopoulos, and D. M. Phillips. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin. Diag. Lab. Immunol. 4(4):465\u2013468 (1997).","journal-title":"Clin. Diag. Lab. Immunol."},{"issue":"3","key":"9073_CR91","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1095\/biolreprod.102.014555","volume":"69","author":"P. Maria-Elisa","year":"2003","unstructured":"P. Maria-Elisa, A. Pirovano, and D. M. Phillips. Carageenan formulation prevents macrophage trafficking from vagina: Implications for microbicide development. Biol. Reprod. 69(3):933\u2013939 (2003).","journal-title":"Biol. Reprod."},{"key":"9073_CR92","doi-asserted-by":"publisher","unstructured":"A. Verhelst. BMC Microbiology. (5)61):DOI 10.1186\/1471-2180-5-61 (2005).","DOI":"10.1186\/1471-2180-5-61"},{"key":"9073_CR93","unstructured":"E. A. Boskey, M. Jansen, I. K. Merski, I. T. Whaley, T. Moench, and R. Cone. BufferGel\u2122 favors in vitro growth of lactobacilli while inhibiting BV-associated organisms [abstract]. Johns Hopkins University and ReProtect, Inc. [serial online]. Abstract A07 (2000)."},{"issue":"9","key":"9073_CR94","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/humrep\/16.9.1809","volume":"16","author":"E. R. Boskey","year":"2001","unstructured":"E. R. Boskey, R. A. Cone, K. J. Whaley, and T. R. Moench. Origin of vaginal acidity: High D\/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 16(9):1809\u20131813 (2001).","journal-title":"Hum. Reprod."},{"issue":"1","key":"9073_CR95","first-page":"21","volume":"26","author":"J. van de Wijgert","year":"2001","unstructured":"J. van de Wijgert, A. Fullem, G. Kelly, et al. Phase I trial of the topical microbicide buffer gel: Safety results from four international sites. J. AIDS. 26(1):21\u201327 (2001).","journal-title":"J. AIDS"},{"issue":"6","key":"9073_CR96","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1095\/biolreprod.104.032870","volume":"71","author":"O. J. D\u2019Cruz","year":"2004","unstructured":"O. J. D\u2019Cruz, P. Samuel, and F. M. Uckun. PHI-443): A novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide. Biol. Reprod. 71(6):2037\u20132047 (2004).","journal-title":"Biol. Reprod."},{"issue":"6","key":"9073_CR97","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.contraception.2004.06.007","volume":"70","author":"E. Amarl","year":"2004","unstructured":"E. Amarl, A. Perdigao, M. H. Souza, C. Mauck, D. Waller, L. Zaneveld, and A. Faundes. Postcoital testing after the use of acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product. Contraception. 70(6):492\u2013497 (2004).","journal-title":"Contraception"},{"key":"9073_CR98","unstructured":"M. J. Durrani. Prolonged release bioadhesive vaginal gel dosage form. US Patent 6159491 (2000)."},{"issue":"3","key":"9073_CR99","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0168-3659(02)00077-9","volume":"81","author":"C. E. Kast","year":"2002","unstructured":"C. E. Kast, C. Valenta, M. Leopold, and A. Bernkop-Schn\u00fcrch. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J. Control Rel. 81(3):347\u2013354 (2002).","journal-title":"J. Control Rel."},{"key":"9073_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev.me.41.020190.000505","volume":"41","author":"D. F. Mosher","year":"1990","unstructured":"D. F. Mosher. Physiology of thrombospondin. Annu. Rev. Med. 41:85\u201389 (1990).","journal-title":"Annu. Rev. Med."},{"key":"9073_CR101","first-page":"633","volume-title":"Peptide and Protein Drug Delivery","author":"H. Okada","year":"1991","unstructured":"H. Okada. Vaginal route of peptide and protein delivery. In V. H. L. Lee (ed.), Peptide and Protein Drug Delivery, Marcel Dekker, New York, 1991, pp. 633\u2013666."},{"issue":"1","key":"9073_CR102","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/abbi.1995.1394","volume":"321","author":"C. Sappey","year":"1995","unstructured":"C. Sappey, J. R. Boelaert, S. Legrandpoels, R. W. Grady, and J. Piette. NF-kB transcription factor activation by hydrogen peroxide can be decreased by 2,3-dihydroxybenzoic acid and its ethyl ester derivative. Arch. Biochem. Biophy. 321(1):263\u2013270 (1995).","journal-title":"Arch. Biochem. Biophy."},{"issue":"8","key":"9073_CR103","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1128\/AAC.46.8.2692-2695.2002","volume":"46","author":"J. A. Simoes","year":"2002","unstructured":"J. A. Simoes, D. M. Citron, A. Aroutcheva, R. A. Anderson, C. J. Chany, D. P. Waller, S. Faro, and L. J. D. Zaneveld. Two novel vaginal microbicides (Polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis. Antimicrob. Agents Chemother. 46(8):2692\u20132695 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR104","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/j.1939-4640.2000.tb03417.x","volume":"21","author":"R. A. Anderson","year":"2000","unstructured":"R. A. Anderson, K. A. Feathergill, X. H. Diao, M. D. Cooper, R. Kirkpatrick, P. Spear, D. P. Waller, C. J. Chany, G. F. Doncel, B. C. Herold, and D. L. J. Zaneveld. Evaluation of poly (styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases. J. Androl. 21:862\u2013875 (2000).","journal-title":"J. Androl."},{"key":"9073_CR105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/j.1939-4640.2002.tb02250.x","volume":"23","author":"R. A. Anderson","year":"2002","unstructured":"R. A. Anderson, K. A. Feathergill, X. H. Diao, M. D. Cooper, R. Kirkpatrick, W. F. Rencher, D. P. Waller, C. J. Chany, G. F. Doncel, B. C. Herold, and L. J. D. Zaneveld. Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent. J. Androl. 23:426\u2013438 (2002).","journal-title":"J. Androl."},{"key":"9073_CR106","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1128\/AAC.45.12.3427-3432.2001","volume":"45","author":"N. D. Christensen","year":"2001","unstructured":"N. D. Christensen, C. A. Reed, T. D. Culp, P. L. Hermonat, M. K. Howett, R. A. Anderson, and L. J. Zaneveld. Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob. Agents Chemother. 45:3427\u20133432 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR107","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/315228","volume":"181","author":"B. C. Herold","year":"2000","unstructured":"B. C. Herold, N. Bourne, D. Marcellino, R. Kirkpatrick, D. M. Strauss, L. J. Zaneveld, D. P. Waller, R. A. Anderson, C. J. Chany, B. J. Barham, L. R. Stanberry, and M. D. Cooper. Poly (sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. J. Infect. Dis. 181:770\u2013773 (2000).","journal-title":"J. Infect. Dis."},{"key":"9073_CR108","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1095\/biolreprod66.4.886","volume":"66","author":"L. J. Zaneveld","year":"2002","unstructured":"L. J. Zaneveld, D. P. Waller, R. A. Anderson, C. Chany, W. F. Rencher, K. Feathergill, K. Diao, G. F. Doncel, B. Herold, and M. Cooper. Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly (sodium 4-styrenesulfonate). Biol. Reprod. 66:886\u2013894 (2002).","journal-title":"Biol. Reprod."},{"key":"9073_CR109","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1086\/314853","volume":"180","author":"N. Bourne","year":"1999","unstructured":"N. Bourne, D. L. Bernstein, J. Ireland, A. J. Sonderfan, A. T. Profy, and L. R. Stanberry. The topical microbicides PRO 2000 protects against genital herpes infection in a mouse model. J Infect Dis. 180:203\u2013205 (1999).","journal-title":"J. Infect Dis."},{"key":"9073_CR110","unstructured":"L. Highleyman. UsherCell microbicides provides no protection against HIV transmission but VivaGel yields promising early data. 4th International Conference on HIV Treatment, Pathogenesis and Prevention, Sydney, Australia (2007)."},{"issue":"1","key":"9073_CR111","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/AAC.34.1.134","volume":"34","author":"M. Baba","year":"1990","unstructured":"M. Baba, D. Schols, E. De Clercq, et al. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrob. Agents Chemother. 34(1):134\u2013138 (1990).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR112","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(07)60202-5","volume":"369","author":"J. Balzarini","year":"2007","unstructured":"J. Balzarini, and L. van Damme. Microbicide drug candidates to prevent HIV infection. The Lancet. 369:787\u2013797 (2007).","journal-title":"The Lancet"},{"issue":"1","key":"9073_CR113","first-page":"543","volume":"1","author":"E. De Clercq","year":"2004","unstructured":"E. De Clercq. New anti-HIV agents in preclinical and clinical development. Frontiers in Med Chem. 1(1):543\u2013579 (2004).","journal-title":"Frontiers in Med Chem."},{"issue":"7","key":"9073_CR114","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/154099903322404302","volume":"12","author":"K. Morrow","year":"2003","unstructured":"K. Morrow, R. Rosen, L. Ritcher, A. Emans, A. Forbes, J. Day, N. Morar, et al. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. J. Women\u2019s Health. 12(7):655\u2013666 (2003).","journal-title":"J. Women\u2019s Health"},{"issue":"4","key":"9073_CR115","first-page":"2","volume":"3","author":"S. N. Joshi","year":"2006","unstructured":"S. N. Joshi, S. Dutta, B. Bell, et al. Phase I safety study of 0.5% PRO 2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Res. Ther. 3(4):2\u20136 (2006).","journal-title":"AIDS Res. Ther."},{"key":"9073_CR116","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.40.1.234","volume":"40","author":"S. Ruscnis","year":"1996","unstructured":"S. Ruscnis, M. Moonis, D. P. Merril, et al. Naphtalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities. Antimicrob. Agents Chemother. 40:234 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR117","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/sti.76.2.126","volume":"76","author":"L. van Damme","year":"2000","unstructured":"L. van Damme, A. Wright, and K. Depraetene. A phase I study of a novel potential intravaginal microbicides, PRO 2000, in healthy sexually inactive women. Sex. Transm. Infect. 76:126 (2000).","journal-title":"Sex. Transm. Infect."},{"key":"9073_CR118","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-6405-3-4","volume":"3","author":"J. Smith","year":"2006","unstructured":"J. Smith, D. Soma, B. Beverly, P. Albert, et al. Phase I safety study of 0.5% PRO 2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Res. Ther. 3:4 (2006).","journal-title":"AIDS Res. Ther."},{"key":"9073_CR119","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002030-200302140-00005","volume":"17","author":"K. H. Mayer","year":"2003","unstructured":"K. H. Mayer, S. A. Karim, C. Kelly, et al. The safety and tolerability of a novel vaginal microbicides, PRO 2000\/5Gel, in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 17:321 (2003).","journal-title":"AIDS"},{"issue":"11","key":"9073_CR120","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1128\/AAC.44.11.3199-3202.2000","volume":"44","author":"K. H. Manson","year":"2000","unstructured":"K. H. Manson, M. S. Wyand, C. Miller, and A. R. Neurath. Effect of cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Antimicrob. Agents Chemother. 44(11):3199\u20133302 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2334-3-27","volume":"3","author":"A. R. Neurath","year":"2003","unstructured":"A. R. Neurath, N. Srick, and Y. Li. Water dispersible microbicidal cellulose acetate phthalate film. BMC Infect. Dis. 3:27 (2003).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"9073_CR122","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1128\/AAC.49.1.323-335.2005","volume":"49","author":"R. N. Fichora","year":"2005","unstructured":"R. N. Fichora, F. Zhou, V. Ratnan, V. Atanassova, S. Giang, N. Strick, and A. R. Neurath. Anti-human immunodeficiency virus type I microbicides cellulose acetate 1,2-benzene dicarbxylate in a human in vitro model of vaginal inflammation. Antimicrob. Agents Chemother. 49(1):323\u2013325 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"9073_CR123","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/sti.75.3.181","volume":"75","author":"H. Thormar","year":"1999","unstructured":"H. Thormar, G. Bergsson, E. Gunnarsson, et al. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex. Transm. Infect. 75(3):181\u2013185 (1999).","journal-title":"Sex. Transm. Infect."},{"issue":"1","key":"9073_CR124","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<107::AID-JMV17>3.0.CO;2-W","volume":"61","author":"K. T. J. Neyts","year":"2000","unstructured":"K. T. J. Neyts, E. De Clercq, and H. Thormar. Hydrogels containing monocaprin prevent intravaginal and intracutaneous infections with HSV-2 in mice: Impact on the search for vaginal microbicides. J. Med. Virol. 61(1):107\u2013110 (2000).","journal-title":"J. Med. Virol."},{"issue":"10","key":"9073_CR125","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/js9900396","volume":"88","author":"T. Kristmundsd\u00f3ttir","year":"2000","unstructured":"T. Kristmundsd\u00f3ttir, S. G. \u00c1rnad\u00f3ttir, G. Bergsson, and H. Thormar. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient. J. Pharm. Sci. 88(10):1011\u20131015 (2000).","journal-title":"J. Pharm. Sci."},{"key":"9073_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0939-6411(00)00121-1","volume":"50","author":"L. Maggi","year":"2000","unstructured":"L. Maggi, P. Mastromarino, S. Macchia, P. Brigidi, F. Pirovano, D. Matteuzzi, and U. Conte. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur. J. Pharm. Biopharm. 50:389\u2013395 (2000).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"9073_CR127","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1128\/AAC.44.7.1954-1960.2000","volume":"44","author":"F. C. Krebs","year":"2000","unstructured":"F. C. Krebs, R. S. Miller, B. J. Catalone, P. A. Welsh, et al. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9): Comparative sensitivity of primary human vaginal keratinocytes. Antimicrob. Agents Chemother. 44(7):1954\u20131960 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR128","first-page":"12","volume":"1","author":"B. Gadi","year":"2001","unstructured":"B. Gadi, and M. A. Parniak. Anti-HIV-1 microbicide potential of the tight-binding non-nucleoside reverse transcriptase inhibitor UC781. AIDScience. 1:12 (2001).","journal-title":"AIDScience"},{"key":"9073_CR129","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1128\/AAC.00984-06","volume":"51","author":"M. Kerr","year":"2007","unstructured":"M. Kerr. NNRTI shows safety as a topical anti-HIV microbicide in animal tests. Antimicrob. Agents Chemother. 51:1608\u20131615 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"9073_CR130","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1097\/01.aids.0000247128.27505.28","volume":"20","author":"E. De Clercq","year":"2006","unstructured":"E. De Clercq. The role of tenofovir in the prevention of HIV infections. AIDS. 20(15):1990\u20131991 (2006).","journal-title":"AIDS"},{"key":"9073_CR131","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.fertnstert.2003.08.037","volume":"81","author":"O. J. D\u2019Cruz","year":"2003","unstructured":"O. J. D\u2019Cruz. Stampidine is a potential nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicides. Fertil. Steril. 81:831\u2013841 (2003).","journal-title":"Fertil. Steril."},{"issue":"4","key":"9073_CR132","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2165\/00137696-200301040-00006","volume":"1","author":"O. J. D\u2019Cruz","year":"2003","unstructured":"O. J. D\u2019Cruz, P. Samuel, B. Waurzyniak, and F. M. Uckun. In vivo evaluation of a gel formulation of stampidine, a novel non-spermicidal broad-spectrum anti-HIV microbicide. Am. J. Drug Deliv. 1(4):275\u2013285 (2003).","journal-title":"Am. J. Drug Deliv."},{"key":"9073_CR133","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.41.7.1521","volume":"41","author":"M. R. Boyd","year":"1997","unstructured":"M. R. Boyd, K. R. Gustfson, J. B. Mc Mahon, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-ianactivating protein that binds viral surface envelope glycoprotein gp 120: potential application to microbicide development. Antimicrob. Agents Chemother. 41:1521\u20131530 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR134","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A","volume":"20","author":"E. De Clercq","year":"2000","unstructured":"E. De Clercq. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 20:323\u2013349 (2000).","journal-title":"Med. Res. Rev."},{"key":"9073_CR135","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1128\/AAC.48.10.3858-3870.2004","volume":"48","author":"J. Balzarini","year":"2004","unstructured":"J. Balzarini, S. Hatse, K. Vermeire, K. Princen, S. Aquaro, C. F. Perno, et al. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrob. Agents Chemother. 48:3858\u20133870 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR136","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(05)70271-1","volume":"5","author":"J. Balzarini","year":"2005","unstructured":"J. Balzarini. Targeting the glycans of gp120: a novel approach aimed at the achilles heel of HIV. Lancet Infect. Dis. 5:726\u2013731 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"9073_CR137","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/088922203322230897","volume":"19","author":"C. C. Tsai","year":"2003","unstructured":"C. C. Tsai, P. Emau, Y. Jiang, B. Tian, W. R. Morton, K. R. Gustafson, et al. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retrovir. 19:535\u2013541 (2003).","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"10","key":"9073_CR138","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1128\/AAC.00493-06","volume":"50","author":"L. Xiaowen","year":"2006","unstructured":"L. Xiaowen, L. A. Lagenaur, and D. A. Simpson. Engineered vaginal Lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob. Agents Chemother. 50(10):3250\u20133259 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR139","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1021\/np0103362","volume":"64","author":"B. R. O\u2019 Keef","year":"2001","unstructured":"B. R. O\u2019 Keef. Biologically active proteins from natural product extracts. J. Nat. Prod. 64:1373\u20131381 (2001).","journal-title":"J. Nat. Prod."},{"key":"9073_CR140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/aem.38.2.314-322.1979","volume":"38","author":"R. L. Ward","year":"1979","unstructured":"R. L. Ward, and C. S. Ashley. pH modification of the effects of detergents on the stability of enteric viruses. Appl. Environ. Microbiol. 38:314\u2013322 (1979).","journal-title":"Appl. Environ. Microbiol."},{"key":"9073_CR141","unstructured":"S. Roy, J. Piret, N. Gagne et al. Thermoreversible gel containing sodium lauryl sulfate as a potential topical microbicide for the prevention of STDs\/HIV. Natl HIV Prev Conf Natl HIV Prev Conf., Atlanta GA 1999."},{"key":"9073_CR142","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/JCM.38.1.110-119.2000","volume":"38","author":"J. Piret","year":"2000","unstructured":"J. Piret, J. Lamontagne, J. Bestman-Smith, S. Roy, P. Gourde, A. D\u00e9sormeaux, R. F. Omar, J. Juh\u00e1sz, and M. G. Bergeron. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J. Clin. Microbiol. 38:110\u2013119 (2000).","journal-title":"J. Clin. Microbiol."},{"key":"9073_CR143","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/jac\/43.2.314","volume":"43","author":"M. K. Howett","year":"1999","unstructured":"M. K. Howett, E. B. Neely, N. D. Christensen, B. Wigdahl, F. C. Krebs, D. Malamud, S. D. Patrick, M. D. Pickel, P. A. Welsh, C. A. Reed, M. G. Ward, L. R. Budgeon, and J. W. Kreider. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob. Agents Chemother. 43:314\u2013321 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9073_CR144","unstructured":"M. Smith. TMC 120 vaginal ring promising as microbicides carrier. XVI International Conference, Toronto Canada, 2006."},{"key":"9073_CR145","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.idc.2007.01.009","volume":"21","author":"J. Nutall","year":"2007","unstructured":"J. Nutall, J. Romano, and K. Douville. The future of HIV prevention: Prospects of an effective anti-HIV microbicide. Infect. Dis. Clin. North Am. 21:219\u2013239 (2007).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"9073_CR146","unstructured":"Molecular trees bear fruit. Vogtle. Available at: http:\/\/www.rsc.org\/chemistryworld\/restricted\/2007\/May\/MolecularTreesBearFruit.asp. Accessed June 9, 2007."},{"issue":"3","key":"9073_CR147","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/aid.2005.21.207","volume":"21","author":"Y. Jiang","year":"2005","unstructured":"Y. Jiang, P. Emau, J. S. Cairns, et al. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV in macaques. AIDS Res. Hum. Retrovir. 21(3):207\u2013213 (2005).","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"12","key":"9073_CR148","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1128\/AAC.47.12.3784-3788.2003","volume":"47","author":"D. I. Bernstein","year":"2003","unstructured":"D. I. Bernstein, L. R. Stanberry, S. Sacks, et al. Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob. Agents Chemother. 47(12):3784\u20133788 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"9073_CR149","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.electacta.2005.04.071","volume":"51","author":"K. Cho","year":"2005","unstructured":"K. Cho, J. Park, T. Osaka, and S. Park. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim. Acta. 51(5):956\u2013960 (2005).","journal-title":"Electrochim. Acta."},{"key":"9073_CR150","unstructured":"Protein-noble metal nanoparticles. US Patent 0115495. Yacaman MJ, Elechiquerra JL, Lara HH and Burt JL. Available at: http:\/\/www.freepatentsonline.com\/20060115495. Accessed June 5, 2007."},{"issue":"6","key":"9073_CR151","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1128\/AEM.02218-06","volume":"73","author":"S. Pal","year":"2007","unstructured":"S. Pal, Y. K. Tak, and J. M. Song. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 73(6):1712\u2013172 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"9073_CR152","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0169-409X(92)90008-E","volume":"8","author":"J. L. Richardson","year":"1992","unstructured":"J. L. Richardson, and L. Illum. The vaginal route of peptide and protein drug delivery. Adv. Drug. Deliv. 8:341\u2013366 (1992).","journal-title":"Adv. Drug. Deliv."},{"issue":"18","key":"9073_CR153","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1097\/QAD.0b013e3280112cd1","volume":"20","author":"E. Barbara","year":"2006","unstructured":"E. Barbara, F. Valeria, and E. Fabrizio. Candidate HIV-1 tat vaccine development from basic science to clinical trials. AIDS. 20(18):2245\u20132261 (2006).","journal-title":"AIDS"},{"issue":"2","key":"9073_CR154","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jmv.10279","volume":"69","author":"T. Akagi","year":"2003","unstructured":"T. Akagi, M. Kawamura, M. Ueno, M. Baba, et al. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice. J. Med. Virol. 69(2):163\u2013172 (2003).","journal-title":"J. Med. Virol."},{"key":"9073_CR155","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(SICI)1096-9071(199812)56:4<327::AID-JMV7>3.0.CO;2-A","volume":"56","author":"T. Hayakawa","year":"1998","unstructured":"T. Hayakawa, M. Kawamura, M. Okamoto, M. Baba, et al. Concanavalin A-immobilized polystyrene nanospheres capture HIV-1 virions and gp120: Potential approach towards prevention of viral transmission. J. Med. Virol. 56:327\u2013331 (1998).","journal-title":"J. Med. Virol."},{"issue":"2","key":"9073_CR156","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00137696-200301020-00001","volume":"1","author":"A. Carmen","year":"2003","unstructured":"A. Carmen, and C. Angel. Effects of surfactants on gel behaviour: Design implications for drug delivery systems. Am. J. Drug Deliv. 1(2):77\u2013101 (2003).","journal-title":"Am. J. Drug Deliv."},{"issue":"6","key":"9073_CR157","first-page":"157","volume":"6","author":"R. Bob","year":"2000","unstructured":"R. Bob. Microbicide. Fashioning new tools to deter HIV transmission. Int. Assoc. Physicians AIDS Care. 6(6):157 (2000).","journal-title":"Int. Assoc. Physicians AIDS Care"},{"issue":"6","key":"9073_CR158","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1128\/AAC.48.6.2025-2036.2004","volume":"48","author":"N. Cheshenko","year":"2004","unstructured":"N. Cheshenko, M. J. Keller, and V. MasCasullo. Candidate topical microbicides bind herpes simplex virus B and prevent viral entry and cell-to-cell spread. Antimicrob. Agents Chemother. 48(6):2025\u20132036 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"9073_CR159","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jac\/dki056","volume":"55","author":"M. J. Keller","year":"2005","unstructured":"M. J. Keller, A. Tuyam, M. J. Carlucc, et al. Topical microbicides for the prevention of genital herpes infection. J. Antimicrob. Chemother. 55(4):420\u2013423 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"9073_CR160","unstructured":"Microbicides trials get London start. Prevention. Cairns G. Available at: http:\/\/www.guscairns.com\/. Accessed July 23, 2007."},{"issue":"2","key":"9073_CR161","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0897.1994.tb01102.x","volume":"32","author":"R. A. Cone","year":"1994","unstructured":"R. A. Cone, and K. J. Whaley. Monoclonal antibodies for reproductive health: Preventing sexual transmission of disease and pregnancy with topically applied antibodies. Am. J. Reprod Immunol. 32(2):114\u2013131 (1994).","journal-title":"Am. J. Reprod Immunol."},{"key":"9073_CR162","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nbt0496-468","volume":"14","author":"J. K. Sherwood","year":"1996","unstructured":"J. K. Sherwood, L. Zeitlin, K. J. Whaley, R. A. Cone, and W. M. Saltzman. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Nat. Biotechnol. 14:468\u2013471 (1996).","journal-title":"Nat. Biotechnol."},{"key":"9073_CR163","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1095\/biolreprod56.1.153","volume":"56","author":"P. E. Castle","year":"1997","unstructured":"P. E. Castle, K. J. Whaley, T. E. Hoen, T. R. Moench, and R. A. Cone. Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits. Biol. Reprod. 56:53\u2013159 (1997).","journal-title":"Biol. Reprod."},{"key":"9073_CR164","unstructured":"R. A. Cone. Handbook of mucosal immunology. 2nd ed. San Diego: Academic Press by Ogra, Mestecky, Lamm, McGhee, and Bienenstock, 1999."},{"key":"9073_CR165","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3201\/eid0501.990107","volume":"5","author":"L. Zeitlin","year":"1999","unstructured":"L. Zeitlin, R. A. Cone, and K. J. Whaley. Monoclonal antibodies for preventing mucosal transmission of epidemic infectious diseases. Emerg. Infect. Dis. 5:54\u201364 (1999).","journal-title":"Emerg. Infect. Dis."},{"key":"9073_CR166","doi-asserted-by":"crossref","unstructured":"K. Briggs, and L. Zeitlin. An anti-HSV antibody produced in transgenic rice plants prevents HSV-2 infection in mice. Presensted at: Microbicides. 13\u201316 (2000).","DOI":"10.1097\/00002030-200102001-00021"},{"key":"9073_CR167","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1074\/jbc.273.9.4855","volume":"273","author":"R. Crombie","year":"1998","unstructured":"R. Crombie, and R. L. Silverstein. Lysosomal integral membrane protein LIMP II binds thrombospondin-1): structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif. J. Biol. Chem. 273:4855\u20134866 (1998).","journal-title":"J. Biol. Chem."},{"key":"9073_CR168","unstructured":"D. F. Mosher. Available at: http:\/\/www.wisc.edu\/molpharm\/faculty\/mosher.html. Accessed July 23, 2007."},{"issue":"4","key":"9073_CR169","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/108729100317821","volume":"14","author":"R. Crombie","year":"2000","unstructured":"R. Crombie. Mechanism of thrombospondin-1 anti-HIV-1 activity. AIDS Patient Care and STDs. 14(4):211\u2013214 (2000).","journal-title":"AIDS Patient Care and STDs"},{"issue":"1","key":"9073_CR170","first-page":"91","volume":"27","author":"R. Crombie","year":"2001","unstructured":"R. Crombie, K. Kawasaki, K. Hojo, and J. Laurence. Peptides derived from salivary thrombospondin-1 replicate its anti-HIV effect: Potential role in microbicide development. J. AIDS. 27(1):91\u201393 (2001).","journal-title":"J. AIDS"},{"key":"9073_CR171","unstructured":"Adams et al. (1995)"},{"key":"9073_CR172","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1083\/jcb.130.3.503","volume":"130","author":"P. Bornstein","year":"1995","unstructured":"P. Bornstein. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin-1. J. Cell Biol. 130:503\u2013506 (1995).","journal-title":"J. Cell Biol."},{"issue":"5","key":"9073_CR173","first-page":"542","volume":"73","author":"G. Roumeliotis","year":"2006","unstructured":"G. Roumeliotis. SR Pharma claims formulation triumph in siRNA drugs. Alliance for Microbicide Development. 73(5):542\u2013547 (2006).","journal-title":"Alliance for Microbicide Development"},{"key":"9073_CR174","unstructured":"P. Cristofaro, and B. Ramratnam. Prevention Strategies: Vaccines and Microbicides 12th Conference on Retrovirus and Opportunistic Infections. Boston, USA, 2005, pp. 22\u201325."},{"key":"9073_CR175","unstructured":"M. Potts, D. Perlman, M. Mandara, N. Prata, and M. Campbell. Is lime\/lemon juice an effective microbicide? Int Conf AIDS, University of California, Berkeley, CA, United States, 2004. Abstract C11663."},{"key":"9073_CR176","first-page":"2572","volume":"17","author":"J. Turpin","year":"2006","unstructured":"J. Turpin. Yoghurt could help fend off HIV. New Scientist Magazine. 17:2572 (2006).","journal-title":"New Scientist Magazine"},{"key":"9073_CR177","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.anaerobe.2006.06.003","volume":"12","author":"S. P. Voravuthikunchai","year":"2006","unstructured":"S. P. Voravuthikunchai, S. Bilasoi, and O. Supamala. Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe. 12:221\u2013226 (2006).","journal-title":"Anaerobe"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-008-9073-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9073-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T09:59:26Z","timestamp":1708768766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-008-9073-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,2]]},"references-count":177,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9073"],"URL":"https:\/\/doi.org\/10.1208\/s12249-008-9073-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,2]]},"assertion":[{"value":"21 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}